Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

A new covid-19 variant called XEC may spread more easily than past variants, but current vaccines are still effective against ...

The Food and Drug Administration (FDA) has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted.

Health Canada said the vaccine was updated to target the JN.1 variant, an offshoot of Omicron. Nationally, the JN.1 group is currently the main lineage in Canada. The variant set off a massive wave of ...

Health Canada authorized Novavax’s updated COVID-19 vaccine that protects against currently circulating variants of the virus ...

The latest, highly contagious subvariants are driving infections, but new vaccines may help stem the tide of another wave — ...

NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...

The new COVID-19 variant XEC may overtake others in circulation to become dominant in the coming months, experts said, but ...

1 for Novavax’s shot), it shares similarities ... caused by XEC are most likely going to be similar to symptoms you’d ...

Health Canada authorized Moderna's updated COVID-19 vaccine that protects against currently circulating variants of the virus ...

Shares of Novavax Inc. NVAX slid 2.05% to $12.93 Tuesday, on what proved to be an all-around mixed trading session for the ...